Sianty Dewi, Imelda Theodora, Bernadette Dian Novita, Yulia Widyasari, Ricardo Gunadi, Maria Amelia Suhardi, Vincentius Diamantino Supit


Background: The etiology of endometrial lesions varies from benign to malignant. Early detection and management of malignancy give the best prognosis for the patient. While studies in America and Europe report a 3-5% risk of malignancy in women below 50 years and a significant increase up to 75-80% in postmenopausal, the availability of national epidemiologic data is limited, therefore the study is held.Method: A descriptive- retrospective study. Total sampling obtained from endometrial specimens in Pathology Diagnostic Center-Prof JH Lunardhi, Sp.PA(K) from 2015 to 2017, while gestation-related, inadequate sample, and incomplete report are excluded. Data analyzed by IBM SPSS 23.0 version. Result: Data of 560 samples, 90% from curettage, 8% hysterectomy, and 2% hysteroscopy. The majority belonged to the 40-49 age group (44.3%). Secretory phase endometrium is the most common finding in the age group of 20-29 years (26.9%). Proliferative phase endometrium is the most common finding. The highest incidence of endometrial hyperplasia occurred in the age group of 40-49 years, for both typical and non-atypical. Endometrial malignancy was found mostly in the 50-59 years (37.03%). Conclusion: The prevalence of endometrial lesions differed according to age groups, with physiological changes, endometritis, polyps, and hyperplasia were most common under 50 years old and the risk of malignancy increased 4.39 times (p.00) beyond 50 years old.

Save to Mendeley


Endometrial Lesion; Hyperplasia; Age; Menopause; Malignancy

Full Text:



Nnoli MA, Nwafor CC, Obiorah CC, Njoku CC. Prevalence of endometrial lesions in a southern tertiary hospital in Nigeria. Sch J Appl Med Sci. 2015;3(1):72–75. Available from: ISSN 2320%0A-%0A6691.

Country-specific I, Method N, Country-specific M. 273 523 621. 2020[cited 30 Nov 2020]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf

Forae G, Aligbe J. Histopathological patterns of endometrial lesions in patients with abnormal uterine bleeding in a cosmopolitan population J Basic Clin Reprod Sci. 2013;2(2):101. Available from doi: 10.4103/2278-960x.118649.

Tendean GGE, Mewengkang M, Wantania JJE. Kejadian perdarahan uterus abnormal di RSUP Prof. Dr. R. D. Kandou Manado tahun 2015. e-CliniC. 2016;4(2):2-5 Available from doi: 10.35790/ecl.4.2.2016.14395.

Jairajpuri Z, Rana S, Jetley S. Atypical uterine bleeding-histopathological audit of endometrium a study of 638 cases. Al Ameen J Med Sci. 2008;6:21-28 Available from: http://doaj.org/doaj?func=fulltext&aId=1213691.

Wardani RA. Karakteristik perempuan dengan perdarahan uterus abnormal di poli kandungan Rumah Sakit Angkatan Laut dr Ramelan Surabaya tahun 2016. Hang Tuah Med J. 2017;15(1):22-31 Available from doi: 10.30649/htmj.v15i1.11.

Noci I. Aging of the human endometrium: a basic morphological and immunohistochemical study. Eur J Obstet Gynecol. 1995;63(2):181-185 Available from doi: 10.1016/0301-2115(95)02244-9.

Badr TARH, Cindy L, Carmack, Deborah A. 基因的改变NIH public access. Bone. 2011;23(1):1-7 Available from doi: 10.1161/CIRCULATIONAHA.110.956839.

Hileeto D, Fadare O, Martel M, Zheng W. Age-dependent association of endometrial polyps with increased risk of cancer involvement. World J Surg Oncol. 2005. Available from doi: 10.1186/1477-7819-3-8.

Dreisler E, Sorensen SS, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol. 2009. Available from doi: 10.1002/uog.6259.

Archer DF. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol. 1991;165(2):317-322 Available from doi: 10.1016/0002-9378(91)90084-5.

Gredmark T, Kvint S, Havel G, Mattson L. Histopathological findings in women with postmenopausal bleeding. Br J Obstet Gynaecol. 1995;102:133-136.

Khare A, Bansal R, Sharma S, Elhence P. Morphological spectrum of endometrium in patients presenting with dysfunctional uterine bleeding. People’s J Sci Res. 2012.

Eckert LO et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol. 2002;186(4):690-695 Available from doi: 10.1067/mob.2002.121728.

Hoffman C, Schorge, Bradshaw, Halvorson, Schaffer. Williams Gynecology. 3rd ed. 2016.

Reed SD et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009. Available from doi: 10.1016/j.ajog.2009.02.032.

Aziz MF. Gynecological cancer in Indonesia. Journal of Gynecologic Oncology. 2009. Available from doi: 10.3802/jgo.2009.20.1.8.

Sofyan N, Sudiana IK, Askandar B. Profile of endometrial cancer patients in the third referral hospital in Surabaya based on known risk factors. Biomol Heal Sci J. 2020;3(2):66 Available from doi: 10.20473/bhsj.v3i2.22141.

Cancer SEER. Uterine cancer-cancer stat facts. Cancer Statistics Facts. 2020. Available from: https://seer.cancer.gov/statfacts/html/corp.html

Casey MJ, Crotzer D. Endometrial Cancer. 2019.

Singh G, Puckett Y. Endometrial hyperplasia. StatPearls. 2020.

Gong TT, Wang YL, Ma XX. Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies. Sci Rep. 2015. Available from doi: 10.1038/srep14051.

Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 10th ed. 2017.

DOI: https://doi.org/10.33508/jwm.v7i1.3167